−0.8TWD
−194.81 MTWD
491.78 MTWD
167.10 M
About TAIMED BIOLOGICS INC.
Sector
Industry
CEO
Chin-Ming Chang
Website
Headquarters
Taipei
Founded
2007
ISIN
TW0004147004
FIGI
BBG000R2VC95
TaiMed Biologics, Inc. engages in the new drug development for human immunodeficiency virus (HIV). Its products include: (1) TMB-355 for the latter part of acquired immune deficiency syndrome (AIDS) medication. (2) TMB-360/365 for anti-AIDS virus. (3) TMB-607 Protease inhibitors for the anti-AIDS virus. The company was founded by David Ho, LanBo Chen and Ing-Wen Tsai on September 4, 2007 and is headquartered in Taipei, Taiwan.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 4147 is 84.8 TWD — it has increased by 2.42% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange TAIMED BIOLOGICS INC. stocks are traded under the ticker 4147.
TAIMED BIOLOGICS INC. is going to release the next earnings report on May 10, 2024. Keep track of upcoming events with our Earnings Calendar.
4147 stock is 2.40% volatile and has beta coefficient of 0.22. Check out the list of the most volatile stocks — is TAIMED BIOLOGICS INC. there?
4147 earnings for the last quarter are −0.02 TWD per share, whereas the estimation was −0.16 TWD resulting in a 87.30% surprise. The estimated earnings for the next quarter are −0.15 TWD per share. See more details about TAIMED BIOLOGICS INC. earnings.
TAIMED BIOLOGICS INC. revenue for the last quarter amounts to 158.00 M TWD despite the estimated figure of 137.50 M TWD. In the next quarter revenue is expected to reach 120.00 M TWD.
Yes, you can track TAIMED BIOLOGICS INC. financials in yearly and quarterly reports right on TradingView.
4147 stock has fallen by 4.50% compared to the previous week, the month change is a 3.75% fall, over the last year TAIMED BIOLOGICS INC. has showed a 23.87% decrease.
4147 net income for the last quarter is −60.29 M TWD, while the quarter before that showed −5.88 M TWD of net income which accounts for −925.62% change. Track more TAIMED BIOLOGICS INC. financial stats to get the full picture.
Today TAIMED BIOLOGICS INC. has the market capitalization of 20.95 B, it has increased by 0.22% over the last week.
No, 4147 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 4147 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TAIMED BIOLOGICS INC. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So TAIMED BIOLOGICS INC. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating TAIMED BIOLOGICS INC. stock shows the sell signal. See more of TAIMED BIOLOGICS INC. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on TAIMED BIOLOGICS INC. future price: according to them, 4147 price has a max estimate of 170.52 TWD and a min estimate of 97.00 TWD. Read a more detailed TAIMED BIOLOGICS INC. forecast: see what analysts think of TAIMED BIOLOGICS INC. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. TAIMED BIOLOGICS INC. EBITDA is −11.47 M TWD, and current EBITDA margin is −2.33%. See more stats in TAIMED BIOLOGICS INC. financial statements.